Mutual Fund Details
NAV
₹17.5273
as on 13 Jun 2025, 10:44 PM
₹-0.0078(0.04%)
Last Change
Scheme Ratings
4
rated by Value Research
Pharma
Rankings based on | as on Invalid date
×
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,89,591
₹2,01,126
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹1,01,126
Profit (absolute return)
101.13%
in the last
1m
3m
1y
3y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
10.31%
In the last 6 months
3.53%
In the last 1 year
18.67%
In the last 3 years
101.13%
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
ITI Pharma and Healthcare Fund Direct - Growth
as of 31 May 2025, 05:30 AM
₹220.85 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
0.47%
Expense Ratio
Plan
Growth
Benchmark
NIFTY Healthcare Total Return Index.
Exit Load
Exit load of 0.50%, if redeemed within 3 months.
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 May 2025
Healthcare
93.84%
₹207.24 Cr
Chemicals
3.64%
₹8.04 Cr
Services
1.29%
₹2.85 Cr
Diversified
0.93%
₹2.05 Cr
Others
0.30%
₹66.25 Lakh
Companies Holding in this Mutual Fund
as on 31 May 2025
Sun Pharmaceutical Industries Ltd.
15.57%
₹34.39 Cr
Dr. Reddy's Laboratories Ltd.
7.53%
₹16.63 Cr
Lupin Ltd.
5.97%
₹13.18 Cr
Apollo Hospitals Enterprise Ltd.
5.81%
₹12.83 Cr
Cohance Lifesciences Ltd.
5.44%
₹12.01 Cr
Others
59.68%
₹131.80 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 May 2025
Sun Pharmaceutical Industries Ltd.
15.57%
₹34.39 Cr
Dr. Reddy's Laboratories Ltd.
7.53%
₹16.63 Cr
Lupin Ltd.
5.97%
₹13.18 Cr
Apollo Hospitals Enterprise Ltd.
5.81%
₹12.83 Cr
Cohance Lifesciences Ltd.
5.44%
₹12.01 Cr
Others
59.68%
₹131.80 Cr
View All
View All
This fund's returns:
26.20%Return Duration
3 Years
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
21.00%
30.86%
3Y Returns
30.86
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
21.00%
30.86%
3Y Returns
30.47
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
21.00%
30.86%
3Y Returns
28.02
About ITI Pharma and Healthcare Fund Direct - Growth
ITI Pharma and Healthcare Fund Direct - Growth is a Equity mutual fund scheme from ITI Mutual Fund. This scheme was launched on Invalid date. It has an AUM of ₹220.85 Crores and the latest NAV decalared is ₹17.527 as on 15 Jun 2025 at 9:49 pm.
ITI Pharma and Healthcare Fund Direct - Growth scheme return performance in last 1 year is 18.67%, in last 3 years is 101.13% and 75.18% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹220.85 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
ITI Mutual Fund
View AMC Details
₹10,274.23 Cr
AUM
56
Schemes
Address
ITI Asset Mangement Limited,ITI House, Building no. 36,Dr. R. K. Shirodkar Marg, Parel,400012
Phone Number
Phone : 022-66214999
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
